214 related articles for article (PubMed ID: 28129308)
1. Comparison of the Efficacy and Safety of Aripiprazole Versus Bupropion Augmentation in Patients With Major Depressive Disorder Unresponsive to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-Label Study.
Cheon EJ; Lee KH; Park YW; Lee JH; Koo BH; Lee SJ; Sung HM
J Clin Psychopharmacol; 2017 Apr; 37(2):193-199. PubMed ID: 28129308
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of aripiprazole or bupropion augmentation and switching in patients with treatment-resistant depression or major depressive disorder: A systematic review and meta-analysis of randomized controlled trials.
Ji M; Feng J; Liu G
PLoS One; 2024; 19(4):e0299020. PubMed ID: 38669232
[TBL] [Abstract][Full Text] [Related]
3. Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder.
Papakostas GI; Petersen TJ; Kinrys G; Burns AM; Worthington JJ; Alpert JE; Fava M; Nierenberg AA
J Clin Psychiatry; 2005 Oct; 66(10):1326-30. PubMed ID: 16259548
[TBL] [Abstract][Full Text] [Related]
4. Medication augmentation after the failure of SSRIs for depression.
Trivedi MH; Fava M; Wisniewski SR; Thase ME; Quitkin F; Warden D; Ritz L; Nierenberg AA; Lebowitz BD; Biggs MM; Luther JF; Shores-Wilson K; Rush AJ;
N Engl J Med; 2006 Mar; 354(12):1243-52. PubMed ID: 16554526
[TBL] [Abstract][Full Text] [Related]
5. Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors.
Papakostas GI; Nutt DJ; Hallett LA; Tucker VL; Krishen A; Fava M
Biol Psychiatry; 2006 Dec; 60(12):1350-5. PubMed ID: 16934768
[TBL] [Abstract][Full Text] [Related]
6. Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder.
Simon JS; Nemeroff CB
J Clin Psychiatry; 2005 Oct; 66(10):1216-20. PubMed ID: 16259533
[TBL] [Abstract][Full Text] [Related]
7. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
Clayton AH; Croft HA; Horrigan JP; Wightman DS; Krishen A; Richard NE; Modell JG
J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies.
Papakostas GI; Stahl SM; Krishen A; Seifert CA; Tucker VL; Goodale EP; Fava M
J Clin Psychiatry; 2008 Aug; 69(8):1287-92. PubMed ID: 18605812
[TBL] [Abstract][Full Text] [Related]
9. Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study.
Thase ME; Fava M; DeBattista C; Arora S; Hughes RJ
CNS Spectr; 2006 Feb; 11(2):93-102. PubMed ID: 16520686
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: a meta-analysis of individual patient data from 10 double-blind, randomized clinical trials.
Papakostas GI; Trivedi MH; Alpert JE; Seifert CA; Krishen A; Goodale EP; Tucker VL
J Psychiatr Res; 2008 Jan; 42(2):134-40. PubMed ID: 17631898
[TBL] [Abstract][Full Text] [Related]
11. Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission.
Sheffrin M; Driscoll HC; Lenze EJ; Mulsant BH; Pollock BG; Miller MD; Butters MA; Dew MA; Reynolds CF
J Clin Psychiatry; 2009 Feb; 70(2):208-13. PubMed ID: 19210951
[TBL] [Abstract][Full Text] [Related]
12. Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder.
Papakostas GI; Petersen TJ; Nierenberg AA; Murakami JL; Alpert JE; Rosenbaum JF; Fava M
J Clin Psychiatry; 2004 Feb; 65(2):217-21. PubMed ID: 15003076
[TBL] [Abstract][Full Text] [Related]
13. A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness.
Fava M; Thase ME; DeBattista C
J Clin Psychiatry; 2005 Jan; 66(1):85-93. PubMed ID: 15669893
[TBL] [Abstract][Full Text] [Related]
14. Relative antidepressant efficacy of bupropion and the selective serotonin reuptake inhibitors in major depressive disorder: gender-age interactions.
Papakostas GI; Kornstein SG; Clayton AH; Soares CN; Hallett LA; Krishen A; Tucker VL
Int Clin Psychopharmacol; 2007 Jul; 22(4):226-9. PubMed ID: 17519646
[TBL] [Abstract][Full Text] [Related]
15. Use of bupropion in combination with serotonin reuptake inhibitors.
Zisook S; Rush AJ; Haight BR; Clines DC; Rockett CB
Biol Psychiatry; 2006 Feb; 59(3):203-10. PubMed ID: 16165100
[TBL] [Abstract][Full Text] [Related]
16. An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder.
Iosifescu DV; Nierenberg AA; Mischoulon D; Perlis RH; Papakostas GI; Ryan JL; Alpert JE; Fava M
J Clin Psychiatry; 2005 Aug; 66(8):1038-42. PubMed ID: 16086620
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
Trivedi MH; Thase ME; Fava M; Nelson CJ; Yang H; Qi Y; Tran QV; Pikalov A; Carlson BX; Marcus RN; Berman RM
J Clin Psychiatry; 2008 Dec; 69(12):1928-36. PubMed ID: 19192475
[TBL] [Abstract][Full Text] [Related]
18. An open study of aripiprazole and escitalopram for psychotic major depressive disorder.
Matthews JD; Siefert C; Dording C; Denninger JW; Park L; van Nieuwenhuizen AO; Sklarsky K; Hilliker S; Homberger C; Rooney K; Fava M
J Clin Psychopharmacol; 2009 Feb; 29(1):73-6. PubMed ID: 19142112
[TBL] [Abstract][Full Text] [Related]
19. Open-label study of adjunct modafinil for the treatment of patients with fatigue, sleepiness, and major depression treated with selective serotonin reuptake inhibitors.
Konuk N; Atasoy N; Atik L; Akay O
Adv Ther; 2006; 23(4):646-54. PubMed ID: 17050507
[TBL] [Abstract][Full Text] [Related]
20. Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study.
McIntyre A; Gendron A; McIntyre A
Depress Anxiety; 2007; 24(7):487-94. PubMed ID: 17177199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
